{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:36:32Z","timestamp":1771022192576,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1016\/s0006-8993(97)00531-3","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T00:35:25Z","timestamp":1027643725000},"page":"107-112","source":"Crossref","is-referenced-by-count":136,"title":["A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey"],"prefix":"10.1016","volume":"766","author":[{"given":"Erwan","family":"Bezard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Deloire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bioulac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian E","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0006-8993(97)00531-3_BIB1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson's disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB2","first-page":"83","article-title":"Midbrain dopamine neurons in man: effects of Parkinson's disease on the regional distribution of cells","volume":"12","author":"Askari","year":"1986","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","article-title":"Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of MPTP","volume":"39","author":"Bankiewicz","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(95)00362-O","article-title":"Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a preliminary study","volume":"284","author":"Benazzouz","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00229262","article-title":"MPTP-induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies","volume":"90","author":"Benazzouz","year":"1992","journal-title":"Exp. Brain Res."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB6","doi-asserted-by":"crossref","unstructured":"E. Bezard, T. Boraud, B. Bioulac, C. Gross, Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism, Neuroscience (1997) in press.","DOI":"10.1016\/S0306-4522(97)00226-1"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00001756-199701200-00012","article-title":"Presymptomatic revelation of experimental parkinsonism","volume":"8","author":"Bezard","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB8","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1097\/00001756-199412000-00063","article-title":"Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice","volume":"5","author":"Boireau","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB9","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00001756-199410270-00042","article-title":"Riluzole and experimental parkinsonism: partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo","volume":"5","author":"Boireau","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB10","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB11","first-page":"548","article-title":"Neurochemical and behavioral effects of MPTP in rat, guinea pig and monkey","volume":"20","author":"Chiueh","year":"1984","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogues","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(85)90294-X","article-title":"MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study","volume":"335","author":"Doudet","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(86)90102-8","article-title":"Variability and functional recovery in the MPTP model of parkinsonism in monkeys","volume":"18","author":"Eidelberg","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0922-4106(91)90073-Q","article-title":"MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease","volume":"208","author":"Gerlach","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm0996-1017","article-title":"Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons","volume":"2","author":"Hantraye","year":"1996","journal-title":"Nature Med."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB18","first-page":"387","article-title":"Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus","volume":"48","author":"Hassler","year":"1938","journal-title":"J. Psychol. Neurol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02816113","article-title":"Biochemistry of Parkinson's disease with special reference to the dopaminergic systems","volume":"9","author":"Hirsch","year":"1994","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB22","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1471-4159.1981.tb10843.x","article-title":"Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease","volume":"36","author":"Javoy-Agid","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00001756-199503000-00009","article-title":"Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral but not at the striatal level in mice","volume":"6","author":"Kupsch","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870060205","article-title":"Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism","volume":"6","author":"Kurlan","year":"1991","journal-title":"Movement Disord."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410290618","article-title":"The time-course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of MPTP to monkeys","volume":"26","author":"Kurlan","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in human due to a product of meperidine analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey","volume":"292","author":"Langston","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870070103","article-title":"Core assessment program for intracerebral transplantations (CAPIT)","volume":"7","author":"Langston","year":"1992","journal-title":"Mov. Disord."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0306-4522(90)90077-H","article-title":"Neuronal basis of the parkinsonian resting tremor: a hypothesis and its implication for treatment","volume":"35","author":"Par\u00e9","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(92)90108-J","article-title":"Neuroprotective action of riluzole in rodent models of global and focal cerebral ischemia","volume":"140","author":"Pratt","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(93)90800-W","article-title":"Age-related effects of MPTP treatment of common marmosets","volume":"230","author":"Rose","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(89)90550-8","article-title":"Increased dopamine turn-over may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP","volume":"101","author":"Rose","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410260409","article-title":"Striatal dopamine deficiency in Parkinson's disease: role of aging","volume":"26","author":"Scherman","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(90)90069-N","article-title":"Chronic exposure to low doses of MPTP","volume":"519","author":"Schneider","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(94)01332-C","article-title":"Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion","volume":"672","author":"Schneider","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0006-8993(87)90691-3","article-title":"Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP","volume":"411","author":"Schneider","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0304-3940(85)90204-6","article-title":"Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism","volume":"59","author":"Schultz","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0301-0082(90)90003-Y","article-title":"MPTP-induced parkinsonism","volume":"34","author":"Stern","year":"1990","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/S0006-8993(97)00531-3_BIB39","doi-asserted-by":"crossref","unstructured":"J.R. Taylor, J.D. Elsworth, R.H. Roth, J.R. Sladek, D.E. Redmond, Behavioral effects of MPTP administration in the Vervet monkey, a primate model of Parkinson's disease, in: M.L. Woodruff, A. Nonneman (Eds.), Toxin-induced Models of Neurological Disorders, Plenum Press, New York, 1994, pp. 139\u2013151.","DOI":"10.1007\/978-1-4899-1447-7_6"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.42.2.407","article-title":"Tremor in MPTP-induced parkinsonism","volume":"42","author":"Tetrud","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","article-title":"Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists","volume":"349","author":"Turski","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0028-3908(89)90122-6","article-title":"Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin","volume":"28","author":"Ueki","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB44","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/WNL.35.8.1215","article-title":"Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions","volume":"35","author":"Uhl","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(97)00531-3_BIB45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.1992.tb09429.x","article-title":"MK-801 prevents MPTP-induced parkinsonism in primates","volume":"2","author":"Zuddas","year":"1992","journal-title":"J. Neurochem."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899397005313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899397005313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T19:25:07Z","timestamp":1555442707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899397005313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["S0006899397005313"],"URL":"https:\/\/doi.org\/10.1016\/s0006-8993(97)00531-3","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}